Hemodialysis and Peritoneal Dialysis Market

Hemodialysis and Peritoneal Dialysis Market Size, Share, Growth Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables), By End Use (Home-based, Hospital-based), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2277 | Region: Global | Published Date: November, 2024
Pages: 188 | Tables: 140 | Figures: 74

Hemodialysis and Peritoneal Dialysis Market Insights

Global Hemodialysis and Peritoneal Dialysis Market size was valued at USD 81.11 billion in 2022 and is poised to grow from USD 86.38 billion in 2023 to USD 142.97 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

In recent times, the demand for hemodialysis and peritoneal dialysis is constantly increasing due to lack of organ doners, increasing prevalence of acute kidney injury, and risks related to transplants. Furthermore, innovations in technology and initiatives by key players are launching innovative products and services in the market. Conditions that decrease kidney functions can result in chronic kidney diseases. This develops into End-Stage Renal Disease (ESRD). The growing incidence of CKD is also boosting the demand for dialysis products. Renal diseases and renal failures are becoming more frequent among the population owing to rising cases of diabetes and hypertension. One of the key impacts of both type 1 and type 2 diabetes is diabetic nephropathy. This is triggered by damage to the kidney’s blood artery clusters that help in removing waste process of the body and leads to renal damage. Diabetes is also increasing among people owing to aging, obesity, and unhealthy lifestyle, contributing to the development of the market. Today, diabetes is one of the most common diseases globally.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Hemodialysis and Peritoneal Dialysis Market size was valued at USD 81.11 billion in 2022 and is poised to grow from USD 86.38 billion in 2023 to USD 142.97 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The market is extremely dynamic with the presence of many local organizations. These market players are trying to get more market share by engaging in strategies, like investments, partnerships, and acquisitions & mergers. Many companies are investing more money in the advancement of dialysis and improving patient experience. Furthermore, they are also focusing on maintaining competitive pricing, which is intensifying the competition in the market. Companies are also constantly investing in research and development initiatives to stay ahead and increase their market presence in this ever-changing business setting. 'Fresenius Medical Care AG (Germany) ', 'Baxter (US) ', 'Davita Inc. (US) ', 'Nikkiso Co., Ltd. (Japan) ', 'B. Braun SE (Germany) ', 'Medtronic (US) ', 'Asahi Kasei Corporation (Japan) ', 'Terumo Corporation (Japan) ', 'Toray Medical Co., Ltd. (Japan) ', 'Nipro Corporation (Japan) ', 'Diaverum AB (Sweden) ', 'Dialife SA (Switzerland) ', 'Isopure Corp. (US) ', 'Rockwell Medical, Inc. (US) ', 'Becton, Dickinson and Company (US) ', 'JMS Co. Ltd. (Japan) ', 'Allmed Medical Products Co., Ltd. (China) ', 'Atlantic Biomedical (US) ', 'AngioDynamics (US) ', 'Amecath (Egypt) ', 'Cook (US) ', 'Medical Components Inc. (US) ', 'Polymedicure (India) ', 'Xylem (US) ', 'Outset Medical, Inc. (US)'

The growing awareness campaigns about kidney diseases and availability of treatment options are boosting early diagnosis and intervention. It is extending the patient base for dialysis therapies. Initiatives like World Kidney Day increases awareness about kidney health globally. This is encouraging people to go through regular screenings. Furthermore, early detection allows timely intervention and initiatives of dialysis treatment are accelerating the growth of the market by addressing the requirements of people.

Increasing Opportunities in Emerging Markets: The growing markets offer immense opportunities for growth in the hemodialysis market. This is mainly due to the rising incidences of chronic kidney disease (CKD), enhancing medical structure, and increasing access to renal replacement treatment. Organizations can capitalize on these development prospects by extending into developing economies with cost-efficient solutions tailored to local requirements.

Based on region, North America is dominating the hemodialysis and peritoneal dialysis market. This is because key market players and government bodies are investing in the development of innovative healthcare equipment. Governments are also offering favorable reimbursement, which is immensely contributing to the expansion of the market. The demand for dialysis is increasing constantly due to the prevalence of kidney failures and chronic kidney diseases. Some of the other factors that are boosting the market expansion are increasing medical expenses, government initiatives, and rising disposable income. The rising incidences of obesity and diabetes is leading to increasing kidney disorders, boosting the growth of the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Hemodialysis and Peritoneal Dialysis Market

Report ID: SQMIG35D2277

$5,300
BUY NOW GET FREE SAMPLE